Gabriel Chamie, MD
CFAR Mentor
Associate Professor, School of Medicine
Email: gabriel.chamie@ucsf.edu
Biography
Gabriel Chamie, MD, MPH is an Associate Professor of Medicine and a faculty member in the Division of HIV, Infectious Diseases and Global Medicine at the University of California, San Francisco (UCSF). Dr. Chamie has been conducting HIV and TB clinical and epidemiological research in sub-Saharan Africa since 2008. His research interests include community-based HIV and tuberculosis (TB) diagnosis, TB/HIV co-infection, and TB transmission dynamics in settings with generalized HIV epidemics. He is a co-investigator in the SEARCH Trial of a “test and treat” approach in East Africa, and currently serves as Chair of the SEARCH Trial HIV Testing Working Group implementing large-scale, multi-disease community health campaigns and population-wide HIV testing. He is also co-Principal Investigator of the IBIS-Health study, investigating novel incentive approaches to increase HIV testing among men in rural Uganda. He has an active clinical practice in HIV and TB clinics at San Francisco General Hospital.
Displaying 101 - 107 of 107
- Namusobya J, Semitala FC, Amanyire G, Kabami J, Chamie G, Bogere J, Jain V, Clark TD, Charlebois E, Havlir DV, Kamya M, Geng EH. High retention in care among HIV-infected patients entering care with CD4 levels >350 cells/µL under routine program conditions in Uganda. Clin Infect Dis. 2013 Nov; 57(9):1343-50.
- Luetkemeyer AF, Getahun H, Chamie G, Lienhardt C, Havlir DV. Tuberculosis drug development: ensuring people living with HIV are not left behind. Am J Respir Crit Care Med. 2011 Nov 15; 184(10):1107-13.
- Ruel TD, Zanoni BC, Ssewanyana I, Cao H, Havlir DV, Kamya M, Achan J, Charlebois ED, Feeney ME. Sex differences in HIV RNA level and CD4 cell percentage during childhood. Clin Infect Dis. 2011 Sep; 53(6):592-9.
- Carrico AW, Riley ED, Johnson MO, Charlebois ED, Neilands TB, Remien RH, Lightfoot MA, Steward WT, Weinhardt LS, Kelly JA, Rotheram-Borus MJ, Morin SF, Chesney MA. Psychiatric risk factors for HIV disease progression: the role of inconsistent patterns of antiretroviral therapy utilization. J Acquir Immune Defic Syndr. 2011 Feb 01; 56(2):146-50.
- Chamie G, Charlebois ED, Srikantiah P, Walusimbi-Nanteza M, Mugerwa RD, Mayanja H, Okwera A, Whalen CC, Havlir DV. Mycobacterium tuberculosis microbiologic and clinical treatment outcomes in a randomized trial of immediate versus CD4(+)-initiated antiretroviral therapy in HIV-infected adults with a high CD4(+) cell count. Clin Infect Dis. 2010 Aug 01; 51(3):359-62.
- Bhave P, Chamie G. Streptococcus pneumoniae keratitis. J Hosp Med. 2008 Jul; 3(4):353.
- Currier J, Scherzer R, Bacchetti P, Heymsfield S, Lee D, Sidney S, Tien PC, Fat Redistribution and Metabolic Changes in HIV Infection Study Investigators . Regional adipose tissue and lipid and lipoprotein levels in HIV-infected women. . 2008 May 01; 48(1):35-43.